Jubaan (ג'ובאן בע~מ)
Yokne'am Illit, Israel
Jubaan is developing the Gixam™ System, a non-invasive, AI imaging platform designed to predict the presence of GI disorders by analyzing the spectral signature on the tongue generated by the oral microbiome. As a first step, Jubaan is focusing on the early detection of colorectal adenomas aiming to replace fecal occult blood test (FOBT) and fecal immunochemistry test (FIT) as a first step colorectal cancer screening tool.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- jubaan.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Jubaan (ג'ובאן בע~מ)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now